Curtiss-Wright heads into November earnings with the stock down sharply from its highs and options positioning at its most defensive in months — a setup that puts the Q3 print firmly in focus.
The clearest read on market sentiment is in options. Put/call ratio has jumped to 1.33, running nearly 1.7 standard deviations above its 20-day average of 1.08 and closing in on the 52-week high of 1.48. That spike arrived alongside the price decline — the PCR was sitting near 1.0 through most of August and early September before ratcheting higher in the last two sessions. Demand for downside protection is meaningful. The stock has fallen 13.3% over the past month to $550.27, giving back a chunky portion of its prior gains. The next earnings date is November 4, and the historical record adds some context: the last two earnings prints both produced negative day-one moves — down 7.6% after the August 2026 release and down 5.7% the prior quarter. That pattern is likely coloring the current hedging activity.
Short interest, by contrast, tells a much quieter story. Shares short amount to just 2.1% of the free float — a low level that has barely moved this week, falling a modest 1.1% over seven days even as the stock dropped. The borrow market is extremely loose: availability is near the cap at effectively unlimited, and the cost to borrow is a negligible 0.36%, down slightly on the week despite having climbed about 44% over the past month from a trough near 0.25%. There is no speculative pressure in the lending market. Short sellers are not piling in on the weakness — this looks more like long-side de-risking than a bear thesis gaining momentum.
The Street remains broadly constructive but with notable dispersion. Guggenheim initiated with a Buy and a $786 target just last week — a fresh and explicit endorsement that the selloff has moved the stock to an attractive entry. Piper Sandler took the opposite view on initiation, landing at Neutral with a $665 target, effectively flagging the current price as fair value. Stifel and Citigroup both hold cautious ratings (Hold and Neutral respectively) while continuing to raise targets — a pattern that suggests analysts see improving fundamentals without feeling compelled to own the stock aggressively. The consensus mean target of $786 implies roughly 43% upside from current levels, though that gap has widened mechanically as the stock has sold off. On valuation, the trailing P/E has compressed to around 33x from above 37x a month ago, and EV/EBITDA has eased to roughly 23x. The bull case centres on Defence Electronics revenue growing 17.5% year-on-year and a 137% free cash flow conversion rate; bears point to order delays in the same segment, with $50 million in orders having been pushed out of Q3 2025 due to continuing-resolution uncertainty, alongside the broader risks around US defence budget visibility.
Insider activity adds a mildly cautionary note. The 90-day net position is a disposal of roughly 6,500 shares worth just under $4.7 million. The largest single transaction was CEO Lynn Bamford selling 2,500 shares at $758.20 in June — under a pre-arranged 10b5-1 plan, which reduces its signal value considerably. EVP John Watts also sold just under $650,000 of stock at $619 in late August without a plan in place. The one purchase of note was a director buying roughly $149,000 worth at $711 in early August — but with the stock now trading at $550, that position is already offside. The net picture is one of modest executive selling into prior strength, not a conviction cluster in either direction.
Relative to peers, CW is underperforming on the week despite its low short interest. GE gained nearly 4% over the same period and AIR added 1.6%, while BWXT and SARO — the more directly correlated defence names — both fell between 1.5% and 2.1%, suggesting the weakness in CW has a stock-specific component beyond broad sector rotation.
With earnings not until November 4, the next catalyst to watch is whether the options-driven hedging pressure persists or fades if the stock stabilises — and whether any further analyst initiations or estimate revisions shift the current split between the Guggenheim Buy and the Piper Sandler Neutral.
See the live data behind this article on ORTEX.
Open CW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
